Cancer, Smoking
Conditions
Keywords
Smoking cessation, App for quitting smoking, Cancer, Oncology
Brief summary
The goal of this study is to determine whether the novel smartphone application designed specifically for cancer patients to quit smoking (Quit2Heal) provides higher quit rates than the current standard smoking cessation app.
Detailed description
Cigarette smoking has harmful effects on cancer patients' treatment and prognosis, but there are systemic barriers to delivering smoking cessation interventions to cancer patients. One solution for addressing these barriers is to give patients immediate access to smoking cessation treatment via a smartphone application. The Quit2Heal smartphone app is engaging and tailored to the specific needs of cancer patients, and can be integrated into routine cancer care. The goal of this study is to determine whether Quit2Heal provides higher quit rates than the current standard smoking cessation app.
Interventions
The experimental arm includes an intervention using a novel/experimental smartphone smoking cessation app.
The control intervention uses a standard of care smartphone smoking cessation app.
Sponsors
Study design
Eligibility
Inclusion criteria
* age 18 or older * diagnosed with cancer in the past 12 months * has smoked a cigarette (even a puff) in the past 30 days * interested in learning skills to quit smoking * willing to be randomly assigned to either smartphone application * resides in US * has at least daily access to their own smartphone * knows how to login and download a smartphone application from the Apple app store or Android Play app store * willing and able to read in English * not currently using cessation medications or enrolled in other smoking cessation programs, and * has never used the NCI's Quit Guide smartphone application. * willing and able to complete one follow-up survey * willing to provide email, phone, and mailing address.
Exclusion criteria
* The
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 30-day point prevalence abstinence | 2 months post randomization | No smoking in the past 30 days, as reported 2 months post treatment. |
Countries
United States